Keysight Technologies
KEYS NYSE Electronic Equipment & Instruments Financials FY2016βFY2025
Keysight Technologies' revenue rose 8.0% to $5.4 billion in fiscal 2025. Its operating margin was 16.3%, down from 16.7% a year earlier. Free cash flow was $1.3 billion, up 42.6%. It paid out $375 million in dividends and buybacks, 29% of free cash flow. The diluted share count fell 1.1%.
What Keysight Technologies does
No business description yet.
- Legal name
- KEYSIGHT TECHNOLOGIES, INC.
- Fiscal year ends
- October 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001601046-25-000127
0001601046
Revenue and margins
Keysight Technologies had $5.4B of revenue in fiscal 2025, up 8.0% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 10.8% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.3B in fiscal 2025, 23.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Keysight Technologies returned $375M to shareholders in fiscal 2025, 29% of free cash flow. The diluted share count fell 1.1%.
Value Keysight Technologies yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$661M and divides by 173.0M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 43.1x Β· peers 23.4x Β· sector 33.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Keysight Technologies can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $2.1B | $2.0B | $2.5B | $1.8B | $1.9B |
| Debt incl. finance leases | $1.8B | $1.8B | $1.8B | $1.8B | $2.5B |
| Net debt / EBITDA | β0.2x | β0.2x | β0.4x | β0.0x | 0.6x |
| Debt / equity | 0.5x | 0.4x | 0.4x | 0.4x | 0.4x |
| Interest coverage | 13.7x | 16.9x | 17.4x | 9.9x | 9.1x |
| Current ratio | 2.9x | 3.0x | 2.4x | 3.0x | 2.4x |
| Quick ratio | 2.3x | 2.4x | 1.9x | 2.3x | 1.8x |
| Total assets | $7.8B | $8.1B | $8.7B | $9.3B | $11.3B |
| Total liabilities | $4.0B | $3.9B | $4.0B | $4.2B | $5.4B |
| Shareholders' equity | $3.8B | $4.2B | $4.7B | $5.1B | $5.9B |
| Net debt (β = net cash) | β$261M | β$249M | β$678M | β$6.0M | $661M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$7.4M
8 insiders
Of sales under plans
20%
$1.5M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Satish DhanasekaranPresident and CEO, Director | Sold | 3,000 | $364.13 | $1.1M | Form 4 |
| Sep 23, 2026 | Lisa M. PooleVP and Controller | Sold | 200 | $348.01 | $0.1M | Form 4 |
| Sep 21, 2026 | Neil DoughertyEVP and CFO | Sold | 2,000 | $340.79 | $0.7M | Form 4 |
| Sep 4, 2026 | Ingrid A EstradaSVP | Sold | 2,000 | $326.10 | $0.7M | Form 4 |
| Aug 21, 2026 | Jean McClung NyeDirector | Sold | 3,000 | $319.22 | $1.0M | Form 4 |
| Aug 20, 2026 | Ingrid A EstradaSVP | Sold plan | 2,000 | $314.66 | $0.6M | Form 4 |
| Jun 30, 2026 | Ingrid A EstradaSVP | Sold plan | 2,000 | $340.87 | $0.7M | Form 4 |
| Jun 25, 2026 | Satish DhanasekaranPresident and CEO, Director | Sold plan | 507 | $361.32 | $0.2M | Form 4 |
| Jun 2, 2026 | James CullenDirector | Sold | 3,000 | $346.58 | $1.0M | Form 4 |
| Mar 30, 2026 | Richard P HamadaDirector | Sold | 870 | $275.78 | $0.2M | Form 4 |
| Mar 24, 2026 | Jeffrey K LiSVP and Secretary | Sold | 2,000 | $297.19 | $0.6M | Form 4 |
| Mar 24, 2026 | Neil DoughertyEVP and CFO | Sold | 2,000 | $298.37 | $0.6M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 6 / 9 | 6 / 9 | 6 / 9 |
| Accruals ratio | β4.2% | β4.9% | β5.4% |
| Altman Z'' | 6.46 | 6.08 | 5.15 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Keysight Technologies KEYS | $54.5B | 8.0% | 16.3% | 23.8% | 12.1% | 43.1x | 6 | |
| Zebra Technologies ZBRA | $18.6B | 8.3% | 13.0% | 15.4% | 9.7% | 35.3x | 4 | Compare β |
| Teledyne Technologies TDY | $29.3B | 7.9% | 18.8% | 17.6% | 7.8% | 28.6x | 7 | Compare β |
| Roper Technologies ROP | $44.1B | 12.3% | 28.3% | 31.6% | 6.4% | 18.2x | 5 | Compare β |
| Vontier VNT | $4.8B | 3.2% | 18.3% | 14.3% | 15.8% | 14.2x | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $2.9B | $3.2B | $3.9B | $4.3B | $4.2B | $4.9B | $5.4B | $5.5B | $5.0B | $5.4B |
| Gross profit | $1.6B | $1.7B | $2.1B | $2.5B | $2.5B | $3.1B | $3.5B | $3.5B | $3.1B | $3.3B |
| Research and development | $425M | $507M | $624M | $688M | $715M | $811M | $841M | $882M | $919M | $1.0B |
| Operating income | $406M | $148M | β$394M | $711M | $765M | $1.1B | $1.3B | $1.4B | $833M | $876M |
| Interest expense | $47.0M | $80.0M | $83.0M | $80.0M | $78.0M | $79.0M | $79.0M | $78.0M | $84.0M | $96.0M |
| Pretax income | $546M | $598M | $735M | $715M | $761M | $1.0B | $1.3B | $1.4B | $865M | $1.1B |
| Income tax | $31.0M | $77.0M | β$576M | $94.0M | $134M | $116M | $161M | $300M | $251M | $213M |
| Net income | $335M | $102M | $165M | $621M | $627M | $894M | $1.1B | $1.1B | $614M | $850M |
| Diluted EPS | $1.95 | $0.56 | $0.86 | $3.25 | $3.31 | $4.78 | $6.18 | $5.91 | $3.51 | $4.91 |
| Diluted shares | 0.17B | 0.18B | 0.19B | 0.19B | 0.19B | 0.19B | 0.18B | 0.18B | 0.18B | 0.17B |
| Cash flow | ||||||||||
| Cash from operations | $420M | $328M | $555M | $998M | $1.0B | $1.3B | $1.1B | $1.4B | $1.1B | $1.4B |
| Capital expenditure | $91.0M | $72.0M | $132M | $120M | $117M | $174M | $185M | $197M | $154M | $128M |
| Free cash flow | $329M | $256M | $423M | $878M | $899M | $1.1B | $959M | $1.2B | $898M | $1.3B |
| Depreciation and amortization | $134M | $225M | $307M | $306M | $324M | $291M | $220M | $210M | $264M | $268M |
| Stock-based compensation | $49.0M | $56.0M | $59.0M | $82.0M | $92.0M | $103M | $125M | $135M | $137M | $162M |
| Acquisitions | $10.0M | $1.7B | $5.0M | $88.0M | $357M | $178M | $33.0M | $85.0M | $681M | $2.0B |
| Share buybacks | $62.0M | $0.0M | $120M | $159M | $411M | $673M | $849M | $702M | $439M | $375M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $62.0M | $0.0M | $120M | $159M | $411M | $673M | $849M | $702M | $439M | $375M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $783M | $818M | $913M | $1.6B | $1.8B | $2.1B | $2.0B | $2.5B | $1.8B | $1.9B |
| Total debt | $1.1B | $2.0B | $1.3B | $1.8B | $1.8B | $1.8B | $1.8B | $1.8B | $1.8B | $2.5B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $1.9B | $2.2B | $2.4B | $3.2B | $3.4B | $3.8B | $4.2B | $4.8B | $4.3B | $4.3B |
| Current liabilities | $644M | $819M | $1.5B | $1.0B | $1.1B | $1.3B | $1.4B | $2.0B | $1.4B | $1.9B |
| Inventory | $474M | $588M | $619M | $705M | $757M | $777M | $858M | $985M | $1.0B | $1.1B |
| Property and equipment, net | $512M | $530M | $555M | $576M | $595M | $650M | $690M | $761M | $774M | $795M |
| Total assets | $3.8B | $5.9B | $5.8B | $6.6B | $7.2B | $7.8B | $8.1B | $8.7B | $9.3B | $11.3B |
| Total liabilities | $2.3B | $3.6B | $3.4B | $3.6B | $3.9B | $4.0B | $3.9B | $4.0B | $4.2B | $5.4B |
| Shareholders' equity | $1.5B | $2.3B | $2.4B | $3.0B | $3.3B | $3.8B | $4.2B | $4.7B | $5.1B | $5.9B |
| Margins | ||||||||||
| Gross margin | 55.7% | 53.4% | 54.4% | 58.9% | 60.0% | 62.1% | 63.7% | 64.6% | 62.9% | 62.1% |
| Operating margin | 13.9% | 4.6% | β10.2% | 16.5% | 18.1% | 21.9% | 24.6% | 24.9% | 16.7% | 16.3% |
| EBITDA margin | 18.5% | 11.7% | β2.2% | 23.6% | 25.8% | 27.8% | 28.7% | 28.7% | 22.0% | 21.3% |
| Net margin | 11.5% | 3.2% | 4.3% | 14.4% | 14.9% | 18.1% | 20.7% | 19.3% | 12.3% | 15.8% |
| FCF margin | 11.3% | 8.0% | 10.9% | 20.4% | 21.3% | 23.2% | 17.7% | 22.2% | 18.0% | 23.8% |
| Returns | ||||||||||
| Return on capital | 20.5% | 4.8% | β12.4% | 20.6% | 19.3% | 27.9% | 31.4% | 26.8% | 13.0% | 12.1% |
| Return on capital employed | 13.6% | 3.6% | β8.3% | 14.3% | 13.0% | 17.1% | 20.3% | 20.4% | 11.5% | 10.1% |
| Return on equity | 23.8% | 5.3% | 7.0% | 22.8% | 19.9% | 25.3% | 28.3% | 24.0% | 12.6% | 15.5% |
| Return on assets | 9.2% | 2.1% | 2.8% | 10.0% | 9.1% | 11.9% | 14.2% | 12.6% | 6.8% | 8.3% |
| Growth | ||||||||||
| Revenue growth | 2.2% | 9.3% | 21.6% | 11.0% | β1.9% | 17.1% | 9.7% | 0.8% | β8.9% | 8.0% |
| Net income growth | β34.7% | β69.6% | 61.8% | 276.4% | 1.0% | 42.6% | 25.7% | β6.0% | β41.9% | 38.4% |
| EPS growth | β35.0% | β71.3% | 53.6% | 277.9% | 1.9% | 44.4% | 29.3% | β4.4% | β40.6% | 39.9% |
| FCF growth | 15.9% | β22.2% | 65.2% | 107.6% | 2.4% | 27.7% | β16.5% | 26.3% | β25.9% | 42.7% |
| Share count change | 0.6% | 5.8% | 5.0% | 0.0% | β1.1% | β1.1% | β2.7% | β1.7% | β2.2% | β1.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.6x | 3.3x | β | 0.2x | 0.0x | β0.2x | β0.2x | β0.4x | β0.0x | 0.6x |
| Debt / equity | 0.7x | 0.9x | 0.5x | 0.6x | 0.5x | 0.5x | 0.4x | 0.4x | 0.4x | 0.4x |
| Interest coverage | 8.6x | 1.9x | β4.8x | 8.9x | 9.8x | 13.7x | 16.9x | 17.4x | 9.9x | 9.1x |
| Current ratio | 2.9x | 2.7x | 1.6x | 3.2x | 3.1x | 2.9x | 3.0x | 2.4x | 3.0x | 2.4x |
| Quick ratio | 2.1x | 1.9x | 1.2x | 2.5x | 2.4x | 2.3x | 2.4x | 1.9x | 2.3x | 1.8x |
| Capital allocation | ||||||||||
| Capex / revenue | 3.1% | 2.3% | 3.4% | 2.8% | 2.8% | 3.5% | 3.4% | 3.6% | 3.1% | 2.4% |
| Stock comp / revenue | 1.7% | 1.8% | 1.5% | 1.9% | 2.2% | 2.1% | 2.3% | 2.5% | 2.8% | 3.0% |
| Payouts / FCF | 18.8% | 0.0% | 28.4% | 18.1% | 45.7% | 58.6% | 88.5% | 58.0% | 48.9% | 29.3% |
| Quality scores | ||||||||||
| Piotroski F-score | 6.0 | 4.0 | 6.0 | 8.0 | 6.0 | 8.0 | 9.0 | 6.0 | 6.0 | 6.0 |
| Altman Z'' | 4.3 | 2.9 | 2.0 | 4.7 | 4.8 | 5.5 | 6.3 | 6.5 | 6.1 | 5.2 |
| Accruals ratio | β2.3% | β4.7% | β6.6% | β6.1% | β5.6% | β5.7% | β0.3% | β4.2% | β4.9% | β5.4% |
Source: SEC EDGAR XBRL filings (CIK 0001601046). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.